{
  "docId": "019de070-7c63-7128-8a46-f79d73ca634e",
  "docSlug": "e7a5d9b34e946c6ef888782967ccb8f4",
  "documentTitle": "AbCellera | IPO Presentation Deck | 38 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2020-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 38,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "balanced",
  "nDataPoints": 6,
  "notes": "The slide uses a dual-bar chart to compare market growth between two sectors.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-7c63-7128-8a46-f79d73ca634e/6",
  "deckHref": "/decks/019de070-7c63-7128-8a46-f79d73ca634e",
  "deckJsonHref": "/decks/019de070-7c63-7128-8a46-f79d73ca634e.json",
  "deckAnchorHref": "/decks/019de070-7c63-7128-8a46-f79d73ca634e#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.4,
        "x": 0.15,
        "y": 0.45
      },
      "kind": "chart",
      "text": "Antibody Market and Cell Therapy Market growth from 2019 to 2025",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1460b39f-3864-402b-90e0-a35f6d4e8fa7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.35,
        "x": 0.1,
        "y": 0.1
      },
      "kind": "paragraph",
      "text": "New technologies and a new business model are needed to lead antibody discovery and capture the antibody-based therapeutic market.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1bcca4f0-7709-4211-a04a-6639fdcfa228",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.35,
        "x": 0.6,
        "y": 0.15
      },
      "kind": "title",
      "text": "BREAKING BOTTLENECKS IN A $140B+ ANTIBODY THERAPEUTICS MARKET.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "01e9c327-4935-4ce1-b591-fc81f4fcecdd",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 5,
      "beatId": "bbe24364-85c5-4f34-b346-d5a488908a95",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "Slides 5-6 present the problem statement and market sizing",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 6,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "5ab65160-9f66-4d29-b690-0ae15cba8c59",
      "evidence": "Slides 5-6 present the limitations of current technology",
      "position": 0,
      "objective": "What is the cost of not adopting new technology for antibody discovery?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 38,
      "from": 4,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "0790a1a3-4790-4249-807c-1b7d69510973",
      "evidence": "The deck presents a clear 'why' for AbCellera's technology throughout",
      "position": 1,
      "objective": "Why is AbCellera's technology the right solution for antibody discovery?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}